• search hit 1 of 1
Back to Result List

PD1-1-1 Phase Ib study of BI 836880 (VEGF/Ang2 nanobody®) plus ezabenlimab (BI 754091, anti-PD-1 antibody) in patients with solid tumors [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Nicolas Girard, Martin Wermke, Fabrice Barlesi, Dong-Wan Kim, Francois Ghiringhelli, Jaafar Bennouna, Thierry Lesimple, Enriqueta Felip, David Berz, Jong-Seok Lee, Harald Timotheus Landsteiner, Victoria Chen, Girish Jayadeva, Jurgen Alt, Björn Hackanson
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/123133
ISSN:0923-7534OPAC
Parent Title (English):Annals of Oncology
Publisher:Elsevier BV
Place of publication:Amsterdam
Type:Article
Language:English
Year of first Publication:2021
Publishing Institution:Universität Augsburg
Release Date:2025/07/17
Volume:32
Issue:Supplement 4
First Page:S325
DOI:https://doi.org/10.1016/j.annonc.2021.05.550
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie